ASHP Meets with Officials from White House and HHS to Discuss IRA

Published: July 18, 2023
ashp meets with officials from white house and hhs to discuss ira

Today, ASHP Chief Executive Officer Paul W. Abramowitz and leaders from partner organizations met at the White House with Department of Health and Human Services (HHS) Secretary Xavier Becerra and other top officials to discuss the implementation of the Inflation Reduction Act (IRA) of 2022.

During the meeting, Dr. Abramowitz spoke with Secretary Becerra, Chiquita Brooks-LaSure, administrator for the Centers for Medicare & Medicaid Services, and Neera Tanden, an assistant to President Biden and director of the Domestic Policy Council, to emphasize ASHP’s support for IRA provisions that reduce consumer medication costs and highlight ways that health-system pharmacists can help patients understand their benefits.

The IRA aims to reduce the rising prices of medications, with cost-saving provisions for consumers, including out-of-pocket caps for Medicare Part D, as well as changes to federal healthcare spending, notably requirements that the government negotiate with drug manufacturers on prices of certain medications and that manufacturers pay rebates when the cost of their medications rise faster than the inflation rate.

Along with voicing our support for the IRA, ASHP pushed for additional financial support to hospital pharmacies so that patients can have wider access to the care they need. ASHP supports pending legislation in Congress, including the Equitable Community Access to Pharmacist Services Act and the Pharmacy and Medically Underserved Areas Enhancement Act, which would provide direct payments for some pharmacy services. ASHP also raised the need to fully fund pharmacy residency programs to support training the next generation of clinicians.

In addition, ASHP noted that it is the premier organization for tracking drug shortages through its drug shortage list and encouraged the administration to create an inflation rebates framework that protects against shortages.

Other participants in today’s meeting included representatives from CVS, Rite Aid, Walgreens, Walmart, the American Pharmacists Association, the National Association of Chain Drug Stores, and the National Community Pharmacists Association.


Posted July 18, 2023

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information